Target intelligence / Profile preview

Methionine adenosyltransferase 2 subunit beta (MAT2B)

Target
MAT2B
Molecular classification
Enzyme (regulatory/auxiliary subunit), Short-chain dehydrogenase/reductase (SDR) superfamily, Enzyme complex component
01

Overview

Methionine adenosyltransferase 2 subunit beta (MAT2B) is a regulatory, non-catalytic subunit of the methionine adenosyltransferase (MAT) enzyme complex, which catalyzes the biosynthesis of S-adenosylmethionine (SAMe) from methionine and ATP[1][2][3][4]. MAT2B, encoded by the MAT2B gene, forms a complex with the catalytic subunit MAT2A, together regulating the cellular levels and flux of SAMe, the principal methyl donor required for methylation of DNA, histones, and other proteins[1][2][4]. MAT2B belongs to the short-chain dehydrogenase/reductase (SDR) superfamily, possesses NADP(H) binding capacity, and exists as at least two alternatively spliced isoforms with tissue- and context-specific functions[3]. Expression of MAT2B and its catalytic partner MAT2A are upregulated in various cancers (e.g., hepatocellular carcinoma and colon cancer), implicating the MATα2β complex in tumor progression and making it a focus of pharmacological interest for cancer therapy and methylation disorders[1][2][4]. MAT2B interacts with a range of nuclear and cytoplasmic proteins and is crucial for sustaining the epigenetic and signaling environments characteristic of rapidly proliferating cells[1][3]. Resveratrol and NADP can bind MAT2B in vitro, providing structural insights for possible future drug development[3].

Other names
Methionine adenosyltransferase 2 non-catalytic beta subunitMAT2BTGRMSTP045Nbla02999UNQ2435/PRO4995MAT II betaMATIIbetaSDR23E1Methionine adenosyltransferase II betaPutative dTDP-4-keto-6-deoxy-D-glucose 4-reductaseshort chain dehydrogenase/reductase family 23E member 1testicular tissue protein Li 118beta regulatory subunit of methionine adenosyltransferase
02

Mechanism of action

Modulates MAT2A catalytic activity and affinity for its substrates (methionine and ATP), increases flux of SAMe required for cellular methylation reactions, influences signaling and epigenetic regulation through methyl donor supply, functions as a regulatory subunit of the MATα2β complex with tissue-specific expression

03

Biological functions

Regulation of S-adenosylmethionine (SAMe) biosynthesisRegulation of methylation reactions (DNA, proteins, including histones)Regulation of cell proliferationCell signalingChromatin regulationFormation and modulation of the catalytic enzyme complex with MAT2A
04

Disease associations

Cancer (notably hepatocellular carcinoma and colon cancer)HypermethioninemiaLung non-small cell carcinomaOther diseases involving altered methylation dynamics
05

Safety considerations

Global inhibition of methylation processes may result in broad toxicity (since SAMe is a universal methyl donor)possible interference with normal cell growth and DNA/protein methylation in non-cancer tissuesundefined off-target effects or metabolic disturbances
06

Interacting drugs

Resveratrol (demonstrated binding in crystallographic study)

1 more in the full profile.

07

Biomarkers

Upregulation in hepatocellular carcinoma and some colon cancers suggests possible biomarker use in these malignancies (diagnosis, prognosis, patient selection)altered MAT2B expression as a marker of methylation pathway flux

Beyond the preview

Go deeper on Methionine adenosyltransferase 2 subunit beta (MAT2B).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Methionine adenosyltransferase 2 subunit beta (MAT2B).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call